Lung cancer maintenance therapy

Maintenance therapy may help control advanced cancer that has improved but is not gone after initial treatments. Maintenance therapy is ongoing therapy for a disease that is administered after the acute phase of treatment has been completed.

Among those who received maintenance.

Lung cancer maintenance therapy. The goal of maintenance therapy is not to cure the cancer but to “maintain” a remission or prevent or delay the cancer�s return if the cancer is in remission after initial treatment. Among those who received maintenance. 41 in this multicenter, double‐blind, randomized.

Erlotinib is associated with skin toxicities, however their impact is relatively mild and readily manageable over time. Maintenance therapy is ongoing therapy for a disease that is administered after the acute phase of treatment has been completed. We conducted a randomized study to determine the optimal maintenance therapy.

Maintenance therapy may help control advanced cancer that has improved but is not gone after initial treatments. 40 the saturn (sequential tarceva in unresectable lung cancer) phase 3 clinical trial is determining whether erlotinib is effective as maintenance therapy in advanced nsclc. The combination of bevacizumab and pemetrexed has also demonstrated efficacy.

In a large clinical trial, treatment with the immunotherapy drug atezolizumab (tecentriq), combined with a standard chemotherapy regimen, increased survival in patients with this highly aggressive form of lung. Testing maintenance therapy for small cell lung cancer in patients with slfn11 positive biomarker the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Maintenance therapy is now commonly used after initial treatment for several cancers, such as advanced lung cancer, colorectal cancer, and some types of lymphoma.

Despite significant progress in early stage disease, survival rates for advanced disease remain low. Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for Out of the 92 patients with advanced nsclc included in the study, 42 received maintenance therapy with cytotoxic agents, whereas 50 received maintenance therapy without cytotoxic agents.

Maintenance therapy is a treatment strategy that has been investigated extensively in nsclc and has been the subject of considerable recent debate. However, selection of appropriate maintenance therapy depends on several factors, while traditional chinese medicine (tcm) as maintenance therapy is recommended for all kinds of patients. For the first time in more than two decades, a treatment has been shown to improve how long patients with advanced small cell lung cancer (sclc) live.

Mok, md1 and suresh s. Some doctors believe the term continuous therapy is more appropriate since the cancer is essentially being treated on an ongoing basis. Continuing this treatment, known as maintenance therapy, seems to help keep the cancer in check and help some people live longer.

Maintenance therapy is ongoing therapy for a disease that is administered after the acute phase of treatment has been completed. 13.0 mos vs 11.0 mos, p= 0.19 brodowicz et al, lung cancer 2006; In these situations, it can help people live longer.

The goal is to improve quality of life while offering a. What is maintenance therapy for small cell lung cancer?